Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Consciousness, Loss of

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Consciousness, Loss of in 4 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Armitage, MC1
Bryant, RJ1
Page, CB1
Papaseit, E1
Vázquez, A1
Pérez-Mañá, C1
Pujadas, M1
de la Torre, R1
Farré, M1
Nolla, J1
Cybulska, B1
Maxwell, DL1
Polkey, MI1
Henry, JA1

Other Studies

4 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Consciousness, Loss of

ArticleYear
Severe hyponatremia complicated by seizure following 3,4-methylenedioxymethamphetamine ingestion.
    Emergency medicine Australasia : EMA, 2018, Volume: 30, Issue:5

    Topics: Adolescent; Brain Diseases; Eating; Female; Fluid Therapy; Glasgow Coma Scale; Humans; Hyponatremia;

2018
Surviving life-threatening MDMA (3,4-methylenedioxymethamphetamine, ecstasy) toxicity caused by ritonavir (RTV).
    Intensive care medicine, 2012, Volume: 38, Issue:7

    Topics: Blood Component Transfusion; Contraindications; Drug Interactions; Fever; Fluid Therapy; Hallucinoge

2012
Drug-facilitated rape.
    The journal of family planning and reproductive health care, 2002, Volume: 28, Issue:3

    Topics: Alcohol Drinking; Crime Victims; Flunitrazepam; Forensic Medicine; Humans; Memory Disorders; N-Methy

2002
Hyponatraemia and catatonic stupor after taking "ecstasy".
    BMJ (Clinical research ed.), 1993, Nov-27, Volume: 307, Issue:6916

    Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Catatonia; Designer Drugs; Female; Humans; Hyponatremia;

1993